Follow the event on twitter #IGBAMedicinesforEU

For further information and to register on-line, please visit www.medicinesforeurope.com/events

Lucia Romagnoli - T: +44-7562-876873 - E: events@medicinesforeurope.com

Registrations close officially on 5 June 2017 and are subject to availability.

PROGRAMME

Patients

increasing patient

access

Quality

quality, safety and

efficacy

Value

investors in

innovation

Sustainability

160.000 jobs across

Europe

Partnership

key partners for

public health

Wednesday 14 June

16:30

-

18:30

--PRICING & REIMBURSEMENT--

Pre-Conference Workshop 1: Pricing and Reimbursement Policies around Generic and Biosimilar Medicines

Chair | Michele Uda, Director General – Assogenerici and Chair EMAC – Medicines for Europe

Panel

Helder Mota-Filipe, Member of the Executive Board – National Authority of Medicines and Health

Products (Infarmed I.P.)

Stanislav Primožič, Head of Sector for Pharmacoeconomics, Pharmacovigilance and HTA – JAZMP

Jaime Espin, Professor – Andalusian School of Public Health

Victor Lino Mendonça, Head of Policy and Market Access Europe – Mylan

16:30

-

18:30

--ETHICS--

Pre-Conference Workshop 2: International Consensus Framework on Ethics in the Healthcare Sector

Chair | Sophie Peresson, Director, Pharmaceuticals and Healthcare – Transparency International (tbc)

Panel

Ema Paulino, Professional Secretary FIP Executive Committee and President Lisbon and South

Branch of the Portuguese Pharmaceutical Society

Robert Andrew Johnstone, Patient Advocate, Board member – EPF

Sara Perazzi, Membership and Project Manager – International Hospital Federation (tbc)

Edward Kelley, Coordinator and Head of Strategic Programmes, Patient Safety – WHO (tbc)

Heikki Pälve, CEO – Finnish Medical Association

Michael Fadus, Vice President of Compliance – Teva

Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium

T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com

Follow us on

16:30

-

18:30

--COMMUNICATIONS--

Pre-Conference Workshop 3: #AccessHealth, what’s behind a hashtag?

Chair | Brett Kobie, Digital, Social and Creative Lead – Fleishman Hillard

Panel

Aidan Fry, Editor – Generics Bulletin

Paul Tunnah, CEO and Founder – Pharmaphorum

Laetitia Tonel, Head of Communications – Mylan Europe

Chris Lewis, Senior Manager External Communications – Sandoz Global Communications

James Duggan, Principal Medical Writer – 90TEN/IGBA Biosimilar Medicines Communication Project

16:30

-

18:30

--TRADE--

Pre-Conference Workshop 4: Business Opportunities in External Markets and Access to Medicines –

An Assessment of the Global Policy and Markets Committee

Chair | Sergio Napolitano, Legal Affairs and Trade Director – Medicines for Europe

Panel

Alan Sheppard, Principal, Global Generics and Biosimilars, Thought Leadership – QuintilesIMS

Sérgio Paulo Simões, Vice-President/Head Business and Product Development – Bluepharma

David Jauch, Senior Manager Global Regulatory Affairs, Government Relations – Fresenius Kabi

Oleg Syarkevych, Business Development Director – Farmak

Hiddo Houden, Head of Unit, DG Trade – European Commission (tbc)

Koen Nauwelaerts, Quality and Regulatory Manager – Medicines for Europe

20:00

Welcome Cocktail sponsored by and Conference Registrations

Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium

T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com

Follow us on

Thursday 15 June

08:00

Welcome Coffee and Registration

09:00

--OPENING ADDRESS--

Jacek Glinka, President – Medicines for Europe

--OPENING KEYNOTE SPEECH--

Adalberto Campos Fernandes, Minister of Health – Portugal

Margrethe Vestager, Commissioner DG Competition – European Commission (tbc)

09:30

--SUSTAINABILITY--

Better Access, Better Health: our Industry’s Vision on Sustainability of Healthcare

Chair | Adrian van den Hoven, Director General – Medicines for Europe

Panel

Rabia Khan, Health Policy Analyst – OECD

Christa Cepuch, Pharmaceutical Coordinator – MSF - Access Campaign

Alex Harris, CEO – International Health Partners

Robert Andrew Johnstone, Patient Advocate, Board member – EPF

Pierluigi Antonelli, Head of Western Europe – Sandoz

Jacek Glinka, President Europe – Mylan

11:00

Networking Coffee break

11:40

--DEVELOPED MARKETS--

Global Update of Generic Medicines in Developed Markets

Chair | Jim Keon, President – Canadian Generic Pharmaceutical Association

Panel

Alan Sheppard, Principal Thought Leadership Global Generics and Biosimilars – QuintilesIMS

Jeff Watson, President – Global Generics Apotex

Kyozo Inari, Executive Corporate Officer – Sawai Pharmaceutical Co., Ltd. and Chair of International

Affairs Committee – JGA

John McCullough, VP Commercial Generic Portfolio Europe & Global In-line Portfolio Management –

Teva

13:00

Networking Buffet Lunch

Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium

T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com

Follow us on

14:00

--GLOBAL MANUFACTURING--

Making Generic and Biosimilar Manufacturing

Thrive: A Global Policy

Chair | (tbn)

Panel

Gian Mario Baccalini, President –

Aschinfarma and Chair – European Fine

Chemicals Group

Dinesh Dua, Vice Chairman –

Pharmaceuticals Export Promotion

Council of India

Satoshi Kawamura, Senior Vice

President – Nipro Pharma Corporation

Jody Cox, Vice President Federal and

International Affairs, Canadian Generic

Pharmaceutical Association and Vice

President, Biosimilars Canada

--PROCUREMENT--

A Concerted Approach to Tackle Economic and

Regulatory Aspects of Shortages

Chair | Marc-Alexander Mahl, Executive Vice President,

Business Unit Generic Drugs – Fresenius Kabi

Panel

Annie Pannelay, Principal – Economist

Intelligence Unit

Maggie Dolan, Regional Pharmacy Procurement

Specialist – NHS Commercial Solutions Surrey

Aida Batista, Board Member, Director of

Professional Development – EAHP

Marcel T. M. van Raaij, Director Ministry of

Health – The Netherlands

Dominik Tomek, Board Member – EPF

Yi-Yun (April) Wang, Legal Manager - Yung Shin

Pharm. Ind. Co., Ltd. and Chair, International

Affairs Committee – TGPA

15:20

Networking Coffee Break

16:00

--INTERNATIONAL CONVERGENCE--

International Regulatory and Supply Chain

Cooperation

Chair | David Gaugh, Senior Vice President,

Sciences and Regulatory Affairs – AAM

Panel

Sabine Kopp, Group Lead, Medicines

Quality Assurance – WHO

Hideyuki Kondo, MHLW/PMDA Liaison

Official – EMA (tbc)

Mechthild Sander, AET

Paul Hargreaves, Inspection,

Enforcement & Standards Division –

MHRA (tbc)

Brendan Cuddy, Head of Manufacturing

and Quality Compliance – EMA

Fran Zipp, CEO – Lachman Consultant

Services, Inc.

--VALUE ADDED MEDICINES--

A New Value Proposition for Patients, Healthcare

Practitioners and Systems

Chair | Christoph Stoller, Senior Vice-President

Generics and Commercial Operations Europe – Teva

and Vice-President – Medicines for Europe

Panel

Mondher Toumi, Professor – University of Aix-

Marseille

Robert Andrew Johnstone, Patient Advocate,

Board member – EPF

Sampreet Ramachandra, Director of Strategy –

Fresenius Kabi

Stephane Kraehenbuehl, Group leader Clinical

Pharmacy and Head Clinical Pharmacology &

Toxicology – University Hospital Basel (tbc)

Ulf Persson, CEO – Swedish Institute for Health

Economics (tbc)

Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium

T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com

Follow us on

17:20

Closure of the day

17:30

--WOMEN’S LEADERSHIP & PHARMA--

Post-conference cocktail event: Q&A with influential women in healthcare

Chair | Hanan J. Sboul, Secretary General – Jordanian Association of Pharmaceutical Manufacturers

Panel

Carol Lynch, Head Global Biosimilars – Sandoz

Catarina Nobre, President – EPSA

Eleni Antoniadou, President – European Health Parliament

Elisabeth Stampa, CEO – Medichem

Heather Bresch, CEO – Mylan (tbc)

Hildrun Sundseth, President – European Institute for Women’s Health

20:00

Conference Dinner

Friday 16 June

08:00

Networking Coffee

09:00

--OPENING ADDRESS—

Paulo Lilaia, President – Apogen (Portuguese Association for Generic and Biosimilar Medicines)

--OPENING SPEECH—

José Inácio Faria, MEP – EPP Portugal

09:20

--CEO PANEL--

A Discussion with the Global Leaders

Chair | John Hodgson, Executive Editor – In Vivo, Informa Pharma Intelligence Group

Panel

Elisabeth Stampa, CEO – Medichem

Heather Bresch, CEO – Mylan (tbc)

Enrique Ordieres, President – Cinfa

Patrick Aghanian, Head – Zentiva (tbc)

Jeremy B. Desai, CEO – Apotex Inc.

Umang Vohra, CEO – CIPLA (tbc)

Robert Wessman, CEO & Executive Chairman – Alvogen (tbc)

Matthias Wiedenfels, CEO – Stada (tbc)

10:40

Networking Coffee Break

Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium

T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com

Follow us on

11:30

--INVESTORS--

Meet the Investors

Chair | Randall Stanicky, Analyst – RBC Capital Markets

Panel

Frances Cloud, Managing Director – Pharmacloud

Simon Goeller, Partner – McKinsey & Company, Inc.

Tim Jaksland, Innovation Analyst – Carmignac Risk Managers (tbc)

Craig Frances, President – the Healthcare Private Equity Association (tbc)

Dominic Valder, Analyst – FIL (tbc)

Axel Malkomes, Vice Chairman Healthcare Banking – Barclays plc (tbc)

Zoltan Toth, Private Equity Professional (tbc)

12:45 Networking Buffet Lunch

14:00

--BIOSIMILAR MEDICINES--

Global Market Policies for Biosimilar Medicines

Chair | Belinda Wood, CEO – Generic and

Biosimilar Medicines Association (GBMA),

Australia and Vice-Chair of the IGBA Biosimilars

Committee

Panel

Maggie Dolan, Regional Pharmacy

Procurement Specialist – NHS Commercial

Solutions Surrey

Brian Lehman, Manager of pharmacy

benefits and policy – Ohio Public Employees

Retirement System (OPERS)

Suzanne McGurn, Assistant Deputy

Minister and Executive Officer – Ontario

Public Drug Programs

Hiroyuki Sakamaki, Professor – Tokyo

University of Science

Carol Lynch, Head Global Biosimilars –

Sandoz

--EMERGING MARKETS--

Unlocking Pharma Growth – Emerging Markets

Chair | Rafael Enrique Maciel Martínez, President –

AMEGI

Panel

Jean Mina, Associate Partner – McKinsey &

Company

Abdallah Mazahreh, Marketing Director /

MENA & Emerging Markets – Pharma

International Company

Vivian Frittelli, CEO – NAPM (South Africa)

Dilip G Shah, Secretary General – IPA (South

Asia and India)

Keh Song Hock, Executive Director – Malaysian

Organisation of Pharmaceutical Industries

(Southeast Asia)

Talgat Nurgozhin, Director of Center for Life

Sciences – Nazarbaev University, Astana-city,

Editor-in-Chief for Kazakhstan National

Formulary, Vice President ISPOR Kazakhstan

(Central Asia and Eastern Europe)

15:20

--CLOSING REMARKS--

Adrian van den Hoven, Chairman – IGBA

Medicines for Europe AISBL Rue d’Arlon 50 - 1000 Brussels – Belgium

T: +32 (0)2 736 84 11- F: +32 (0)2 736 74 38 www.medicinesforeurope.com

Follow us on

SPONSORS

MEDIA PARTNERS